|本期目录/Table of Contents|

[1]姚晶瑞,姜埃利,王立华,等.雷公藤甲素上调PRDX2抑制2型糖尿病肾病的氧化应激状态[J].天津医科大学学报,2019,25(05):466-470.
 YAO Jing-rui,JIANG Ai-li,WANG Li-hua,et al.Inhibition of Triptolide on oxidase stress via PRDX2 expression in diabetic nephropathy[J].Journal of Tianjin Medical University,2019,25(05):466-470.
点击复制

雷公藤甲素上调PRDX2抑制2型糖尿病肾病的氧化应激状态(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
25卷
期数:
2019年05期
页码:
466-470
栏目:
基础医学
出版日期:
2019-09-20

文章信息/Info

Title:
Inhibition of Triptolide on oxidase stress via PRDX2 expression in diabetic nephropathy
文章编号:
1006-8147(2019)05-0466-05
作者:
姚晶瑞12姜埃利1王立华1魏 芳1陈海燕1于海波1孟 甲1
(1.天津医科大学第二医院肾脏病血液净化科,天津300211;2. 天津市海河医院肾内科,天津300350)
Author(s):
YAO Jing-rui12 JIANG Ai-li1 WANG Li-hua1 WEI Fang1 CHEN Hai-yan1 YU Hai-bo1 MENG Jia1
(1.Department of Renal Disease and Blood Purification, The Second Hospital, Tianjin Medical University, Tianjin 300211,China;2.Department of Nephrology, Haihe Hospital, Tianjin 300350,China)
关键词:
PRDX2雷公藤甲素糖尿病肾病人肾小球系膜细胞
Keywords:
PRDX2 triptolidediabetic nephropathyhuman mesangialcells
分类号:
R587.1
DOI:
-
文献标志码:
A
摘要:
目的:通过观察雷公藤甲素对2型糖尿病肾病小鼠肾脏和人肾小球系膜细胞氧化应激的影响,探讨雷公藤甲素改善2型糖尿病肾病的分子机制。方法:体内实验分3组:C57小鼠对照组、KK-Ay小鼠模型组和KK-Ay小鼠加用雷公藤甲素干预组。雷公藤甲素200 μg/(kg·d)灌胃12周后取肾脏组织进行HE染色;体外实验采用人肾小球系膜细胞为研究对象,分为正常糖组、高糖刺激模型组和雷公藤甲素干预组3组。分别用含有5.5 mmol/L(培养基组成)的D-葡萄糖、30 mmol/L的D-葡萄糖、及30 mmol/L的D-葡萄糖加10 μg/L的雷公藤甲素培养24 h。采用ELISA法检测小鼠肾脏和人肾小球系膜细胞中SOD活性和MDA含量。Western blot方法检测各组小鼠肾脏和人肾小球系膜细胞中PRDX2的蛋白表达量。结果:体内外实验结果均显示,与相应对照组相比,2型糖尿病肾病小鼠模型组肾脏和人肾小球系膜细胞高糖刺激模型组细胞中SOD活性明显下降,MDA含量明显增加,PRDX2蛋白表达水平明显降低(P<0.05);雷公藤甲素干预组较模型组SOD活性明显升高,MDA含量明显减少,同时PRDX2蛋白表达水平明显增加(P<0.05)。结论:雷公藤甲素可以通过上调PRDX2抑制2型糖尿病肾病肾脏氧化应激状态。
Abstract:
Objective: To study the effect of Triptolide on oxidase stress in kidneys of mice with diabetic nephropathy and human mesangial cells. Methods: Three groups of mice were used in the in vivo experiments. The three groups were C57 mice controls, KK-Ay mice models, and test group of KK-Ay mice models by triptolide treatment. At the end of treatment, histopathological examination was done to examine the glomerular injury. The human mesangial cells were used in the in vitro experiments and were divided into three groups, the control group, the high glucose model group, and test group of high glucose by triptolide treatment. The MDA contents and the SOD activities in different groups were detected by ELISA. The PRDX2 protein levels were valued by Western blot. Results: The decreased SOD activities, the increased MDA contents, and the decreased PRDX2 protein levels were determined in kidney of KK-Ay mice models and the high glucose model group compared with the corresponding control groups(P<0.05). However, these three indexes were all reversed by the triptolide treatment in the test groups compared with the corresponding model groups(P<0.05). Conclusion: Triptolide may inhibit oxidase stress in diabetic nephropathy via upregulation of PRDX2 protein levels.

参考文献/References:

[1] 吴航,孙子林.糖尿病肾病的发病机制和药物干预研究进展[J].药学进展,2016,12(5): 337
[2] Jaiswal M,Divers J,Dabelea D, et al. Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes:SEARCH for diabetes in youth study[J]. Diabetes Care,2017,40(9): 1226
[3] Vinik A, Nevoret M L,Casellini C, et al. Diabetic neuropathy[J].Endocrinol Metab Clin North Am,2013,42(4):747
[4] 魏晓,欧三桃.综合防治,延缓进展-2014年版《中国糖尿病肾病防治专家共识》解读[J].实用医学杂志, 2016, 32(1):1
[5] 韩立坤, 李明举, 毛宇, 等. 糖尿病肾病大鼠铁超载对内皮功能及氧化应激的影响[J]. 中国老年学, 2017, 37(22): 5515
[6] 张学磊,金明花,王莹,等.糖尿病肾病患者血清瘦素水平变化与氧化应激的关系[J].中国医药导报, 2016,13(16): 54
[7] 张冬燕,刘保林,刘康.氧化应激与胰岛素抵抗分子机制之联系[J].海峡药学,2012, 24(9):1
[8] 姚志灵, 陈亮, 王志胜, 等. 老年冠心病病人不同糖代谢状态与氧化应激水平的相关性研究[J].中西医结合心脑血管病杂志,2016,14(19): 2273
[9] 凌厉,陈立波,劳国娟,等.雷公藤多苷对糖尿病大鼠肾小球足细胞病变的保护作用[J].中国慢性病预防与控制, 2016, 24(7): 489
[10] 高清.雷公藤甲素对糖尿病肾病的疗效及其机制的研究[D].南京:南京大学,2010
[11] 王丹妮,于蕊.雷公藤甲素对糖尿病肾病大鼠肾组织TNF-α与MCP-1表达的影响[J].解剖科学进展, 2017 (1): 71
[12] 崔进, 陈晓, 苏佳灿. 雷公藤甲素药理作用研究新进展[J]. 中国中药杂志, 2017(14): 2655
[13] 林君容,林兵,宋洪涛.雷公藤甲素与雷公藤红素的体内药动学研究进展[J].中草药, 2016, 47(3): 528
[14] 吕佳璇,李月红.糖尿病肾病的研究进展[J].临床内科杂志,2016, 33(5): 296
[15] 高清,刘志红,秦卫松,等.雷公藤甲素治疗db/db糖尿病小鼠的疗效观察[J].肾脏病与透析肾移植杂志,2009,18(6): 519
[16] 李柯桢,栾健,隋爱华,等. 厄贝沙坦联合雷公藤甲素对2型糖尿病大鼠肾脏ANGPTL2、VEGF表达影响[J]. 中国中西医结合肾病杂志,2013,14(11): 959
[17] 李焱.氧化应激与胰岛素抵抗及其对策[J].实用糖尿病杂志,2007,3(3):6
[18] 殷松楼,周冬梅,奚钰,等. 2型糖尿病患者氧化应激指标的变化[J]. 徐州医科大学学报, 2010, 30(1): 63
[19] 程雯,王华,陈淑雯,等.2型糖尿病患者同型半胱氨酸水平与糖尿病肾病、胰岛素抵抗及糖脂代谢的关系探讨[J].上海预防医学,2016,28(2):125
[20] 操轩,胡亚琳,陈健.早期糖尿病肾病与胰岛素抵抗及微炎症状态之间关系的研究[J].临床内科杂志,2016, 33(1):28
[21] Kashihara N, Haruna Y, Kondeti V K, et al. Oxidative stress in diabetic nephropathy[J].Curr Med Chem, 2010,17(34): 4256
[22] Jha J C, Ho F, Dan C, et al.A causal Link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes[J].Clin Sci, 2018, 132(16): 1811
[23] Malekiyan R, Abdanipour A, Sohrabi D, et al. Antioxidant and neuroprotective effects of lycopene and insulin in the hippocampus of streptozotocin-induced diabetic rats[J].Biomed Rep, 2019, 10(1):47
[24] Neelofar K, Arif Z, Arafat M Y, et al. A study on correlation between oxidative stress parameters and inflammatory markers in type 2 diabetic patients with kidney dysfunction in North Indian population[Z].2018
[25] 夏莉莉,汤瑜斌,邵侃.前列地尔对糖尿病肾病患者血液流变学、免疫功能及MDA、SOD、ROS的影响[J]. 海南医学院学报, 2016, 22(14):1528
[26] 唐莉.DBDCT致肝毒性的蛋白质组学及Trx1介导的氧化应激机制研究[D]. 山西医科大学, 2013
[27] Ji D, Li M, Zhan T, et al. Prognostic role of serum AZGP1, PEDF and PRDX2 in colorectal cancer patients[J]. Carcinogenesis, 2013,34(6):1265
[28] Zhou S L, Han Q L, Wang R, et al. PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress[J].Oncol Lett,2016, 12(3): 2217
[29] 卢伟东.Prdx2通过Wnt/β-catenin信号通路调控结肠癌细胞生长的研究[D].重庆:重庆医科大学, 2014
[30] Xu J,Zhang S R,Wang R, et al. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway[J].Biosci Rep, 2017,37(3):pii: BSR20160447. doi: 10.1042/BSR20160447

相似文献/References:

[1]臧 勇,田 园,李卫东.雷公藤甲素通过调节TGF-β1信号通路和Hippo信号通路影响肾小管上皮细胞的上皮-间充质转化[J].天津医科大学学报,2019,25(03):205.
 ZANG Yong,TIAN Yuan,LI Wei-dong.Triptolide affects epithelial-mesenchymal transition of renal tubular epithelial cells by regulating TGF-β1 and Hippo signaling pathways[J].Journal of Tianjin Medical University,2019,25(05):205.

备注/Memo

备注/Memo:
基金项目 天津市卫生行业2012重点攻关项目(12KG136)
作者简介 姚晶瑞(1982-),男,主治医师,硕士在读,研究方向:肾内;通信作者:姜埃利,E-mail:aili_j@163.com。
更新日期/Last Update: 2019-10-11